Morgan Stanley, ASML
ASML stock dips as Morgan Stanley cuts rating
Morgan Stanley analysts reduced their rating on ASML Holding (ASML) shares from Overweight to Equal-weight, and cut the price target from €925 to €800, citing “late-cycle dynamics” that could impact the company's earnings growth prospects in 2025 and 2026.
Mirum Pharmaceuticals Inc (MIRM) stock saw a decline, ending the day at $38.96 which represents a decrease of $-0.39 or -0.99% from the prior close of $39.35. The stock opened at $39.46 and touched a ...
Shares of Morgan Stanley MS rallied 1.73% to $102.47 Friday, on what proved to be an all-around mixed trading session for the ...
Shares of SK Hynix Inc. plunged, leading peers lower, after Morgan Stanley cut its rating on the Korean memory chipmaker two ...
We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to ...
Morgan Stanley cut its price target for Micron Technology and warned about the future of the memory chip sector.
Shares of Morgan Stanley MS shed 0.25% to $99.84 Tuesday, on what proved to be an all-around mixed trading session for the ...
A significant shareholding is being unloaded to the public.
Zacks.com on MSN23h
Morgan Stanley (MS) Is a Trending Stock: Facts to Know Before Betting on ItMorgan Stanley (MS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...
The tail end of 2024 is seeing a market shift in the stock market as the Federal Reserve has finally signaled that interest ...
Centessa Pharmaceuticals (CNTA) upgraded to Overweight by Morgan Stanley on promising narcolepsy treatment results, stock up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback